VRDN up 13%. What's going on:

 Viridian Therapeutics Inc (VRDN) is trading 13% higher at $24.96 today. The stock is blasting past peers in the healthcare sector this afternoon, and is trading at or breaking into new highs. The price moves are following news of a promising clinical trial of it's therapeutic VRDN-001 on patients. Additionally the company is now offering $175 million of its common stock and series B preferred stock which is helping to amplify the move.

Viridian Therapeutics Inc has been trading between a 52-week high of $25.38 and a 52-week low of $9.47. The stock has a market cap of $684 Million.

Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado , with research and development operations in Waltham, Massachusetts.

As you can imagine, the internet had a few things to say about the price move. Here's a few choice comments from the Reddit Traderverse™:

QuirkyAverageJoe - 1 upvotes - source
$VRDN August 19 $22.5 puts 🐻🩸

QuirkyAverageJoe - 1 upvotes - source
$VRDN August 19 $22.5 puts ❌

FingerResponsible620 - 1 upvotes - source
VRDN puts

QuirkyAverageJoe - 1 upvotes - source
Short $VRDN here ❌

QuirkyAverageJoe - 1 upvotes - source
$VRDN August 19 $20 puts ☠️

QuirkyAverageJoe - 1 upvotes - source
$VRDN 08/19 $22.5 puts 🪦

QuirkyAverageJoe - 0 upvotes - source
$VRDN August 19 $22.5 puts 🐻🩸

rangosh - -1 upvotes - source
Anyone in VRDN